請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43876
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林泰元(Thai-Yen Ling) | |
dc.contributor.author | Chia-Yu Chang | en |
dc.contributor.author | 張嘉裕 | zh_TW |
dc.date.accessioned | 2021-06-15T02:31:20Z | - |
dc.date.available | 2019-12-31 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-08-17 | |
dc.identifier.citation | Al-Hajj, M., M. S. Wicha, et al. (2003). 'Prospective identification of tumorigenic breast cancer cells.' Proc Natl Acad Sci U S A 100(7): 3983-8.
Armstrong, L., M. Stojkovic, et al. (2004). 'Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity.' Stem Cells 22(7): 1142-51. Aguiar Bujanda, D., U. Bohn Sarmiento, et al. (2006). 'Epirubicin, cyclophosphamide and weekly paclitaxel as neoadjuvant chemotherapy for stage II and III breast cancer.' J Cancer Res Clin Oncol 132(5): 332-8. Al-Hajj, M., M. S. Wicha, et al. (2003). 'Prospective identification of tumorigenic breast cancer cells.' Proc Natl Acad Sci U S A 100(7): 3983-8. Ardavanis, A., D. Tryfonopoulos, et al. (2005). 'First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.' Anticancer Res 25(6C): 4493-8. Armstrong, L., M. Stojkovic, et al. (2004). 'Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity.' Stem Cells 22(7): 1142-51. . Asher, R., G. Perides, et al. (1991). 'Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex.' J Neurosci Res 28(3): 410-21. Bedossa, P. and V. Paradis (2003). 'Liver extracellular matrix in health and disease.' J Pathol 200(4): 504-15. Berndt, H. and U. Titze (1969). 'TNM clinical stage classification of breast cancer.' Int J Cancer 4(6): 837-44. Casazza, A. M. and C. R. Fairchild (1996). 'Paclitaxel (Taxol): mechanisms of Resistance.' Cancer Treat Res 87: 149-71. Chambers, A. F., A. C. Groom, et al. (2002). 'Dissemination and growth of cancer cells in metastatic sites.' Nat Rev Cancer 2(8): 563-72. Chan, D. A. and A. J. Giaccia (2007). 'Hypoxia, gene expression, and metastasis.' Cancer Metastasis Rev 26(2): 333-9. Chen Q and Little L et al. (1994).'Integrins-mediated cell adhesion activates mitogen activated protein kinase.' J. Biol. Chem. 269:26602-5 Corti, S., F. Locatelli, et al. (2006). 'Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity.' Stem Cells 24(4): 975-85. Croker, A. K. and A. L. Allan (2008). 'Cancer stem cells: implications for the progression and treatment of metastatic disease.' J Cell Mol Med 12(2): 374-90. Dittmar, T., C. Heyder, et al. (2008). 'Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.' Clin Exp Metastasis 25(1): 11-32. Dontu, G., W. M. Abdallah, et al. (2003). 'In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.' Genes Dev 17(10): 1253-70. Dontu, G. and M. S. Wicha (2005). 'Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia.' J Mammary Gland Biol Neoplasia 10(1): 75-86. Eramo, A., F. Lotti, et al. (2008). 'Identification and expansion of the tumorigenic lung cancer stem cell population.' Cell Death Differ 15(3): 504-14. Fardel, O., V. Lecureur, et al. (1996). 'The P-glycoprotein multidrug transporter.' Gen Pharmacol 27(8): 1283-91. Fillmore, C. M. and C. Kuperwasser (2008). 'Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.' Breast Cancer Res 10(2): R25. Fokas, E., R. Engenhart-Cabillic, et al. (2007). 'Metastasis: the seed and soil theory gains identity.' Cancer Metastasis Rev 26(3-4): 705-15. Garamszegi, N., S. P. Garamszegi, et al. (2009). 'Extracellular matrix-induced gene expression in human breast cancer cells.' Mol Cancer Res 7(3): 319-29. Giaccone, G., M. Donadio, et al. (1988). 'Cisplatin and etoposide in chemotherapy-refractory advanced breast cancer.' Tumori 74(2): 191-3. Ginsberg, M. H., J. C. Loftus, et al. (1990). 'Ligand binding to integrins: common and ligand specific recognition mechanisms.' Cell Differ Dev 32(3): 203-13. Gottesman, M. M., T. Fojo, et al. (2002). 'Multidrug resistance in cancer: role of Grimshaw, M. J., L. Cooper, et al. (2008). 'Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells.' Breast Cancer Res 10(3): R52. Hedley, B. D., D. R. Welch, et al. (2008). 'Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.' Int J Cancer 123(3): 526-34. Heine and Munoz et al. (1990). 'Colocalization of TGF-β1 and collagen I and III, fibronectin, and glycosaminoglycans during lung branching morphogenesis.'Development 109:29-36 Hirano, A., T. Shimizu, et al. (2006). 'The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer.' Anticancer Res 26(1B): 581-4. Hwang-Verslues, W. W., K. J. Chang, et al. (2008). 'Breast cancer stem cells and tumor suppressor genes.' J Formos Med Assoc 107(10): 751-66. Hynes, R. O. (1992). 'Integrins: versatility, modulation, and signaling in cell adhesion.' Cell 69(1): 11-25. Hynes, R. O. (2002). 'Integrins: bidirectional, allosteric signaling machines.' Cell 110(6): 673-87. Karpinich, N. O., M. Tafani, et al. (2002). 'The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.' J Biol Chem 277(19): 16547-52. Kondo, T., T. Setoguchi, et al. (2004). 'Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.' Proc Natl Acad Sci U S A 101(3): 781-6. Kuroi, K., A. Osaki, et al. (1997). 'A Combination Therapy with Mitomycin C, Etoposide, Doxifluridine and Medroxyprogesterone Acetate as Second Line Therapy for Advanced Breast Cancer Refractory to Combination Chemotherapy of Cyclo-phoshamide, Doxorubicin and 5-Fluorouracil.' Breast Cancer 4(2): 115-119. Lapidot, T., C. Sirard, et al. (1994). 'A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.' Nature 367(6464): 645-8. Lee, J. W. and R. L. Juliano (2000). 'alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway.' Mol Biol Cell 11(6): 1973-87. Lehnert, M. (1998). 'Chemotherapy resistance in breast cancer.' Anticancer Res 18(3C): 2225-6. Levayer, R. and T. Lecuit (2008). 'Breaking down EMT.' Nat Cell Biol 10(7): 757-9. Li, C., D. G. Heidt, et al. (2007). 'Identification of pancreatic cancer stem cells.' Cancer Res 67(3): 1030-7. Li, C., C. J. Lee, et al. (2009). 'Identification of human pancreatic cancer stem cells.' Methods Mol Biol 568: 161-73. Mani, S. A., W. Guo, et al. (2008). 'The epithelial-mesenchymal transition generates cells with properties of stem cells.' Cell 133(4): 704-15. Martinez-Hernandez, A. (1984). 'The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver.' Lab Invest 51(1): 57-74. McGee, S. F., F. Lanigan, et al. (2006). 'Mammary gland biology and breast cancer. Conference on Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer Progression.' EMBO Rep 7(11): 1084-8. Mendoza, M. and C. Khanna (2009). 'Revisiting the seed and soil in cancer metastasis.' Int J Biochem Cell Biol 41(7): 1452-62. Nabholtz, J. M., C. Falkson, et al. (2003). 'Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.' J Clin Oncol 21(6): 968-75. Neubauer, G., A. Gottschalk, et al. (1997). 'Identification of the proteins of the yeast U1 small nuclear ribonucleoprotein complex by mass spectrometry.' Proc Natl Acad Sci U S A 94(2): 385-90. Nguyen, D. X., P. D. Bos, et al. (2009). 'Metastasis: from dissemination to organ-specific colonization.' Nat Rev Cancer 9(4): 274-84. O'Brien, V., S. M. Frisch, et al. (1996). 'Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation.' Exp Cell Res 224(1): 208-13. Park, S. J., C. H. Wu, et al. (2004). 'Taxol induces caspase-10-dependent apoptosis.' J Biol Chem 279(49): 51057-67. Patrawala, L., T. Calhoun, et al. (2006). 'Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.' Oncogene 25(12): 1696-708. Plow, E. F., T. A. Haas, et al. (2000). 'Ligand binding to integrins.' J Biol Chem 275(29): 21785-8. Polyzos, A., H. Gogas, et al. (2009). 'Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.' Anticancer Res 29(7): 2851-6. Ponti, D., A. Costa, et al. (2005). 'Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.' Cancer Res 65(13): 5506-11. Pontier, S. M. and W. J. Muller (2008). 'Integrins in breast cancer dormancy.' APMIS 116(7-8): 677-84. Pontier, S. M. and W. J. Muller (2009). 'Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?' J Cell Sci 122(Pt 2): 207-14. Prince, M. E., R. Sivanandan, et al. (2007). 'Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.' Proc Natl Acad Sci U S A 104(3): 973-8. Queirolo, P., L. Repetto, et al. (1991). 'Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.' J Chemother 3(3): 194-7. Ricci-Vitiani, L., D. G. Lombardi, et al. (2007). 'Identification and expansion of human colon-cancer-initiating cells.' Nature 445(7123): 111-5. Rojkind, M., M. A. Giambrone, et al. (1979). 'Collagen types in normal and cirrhotic liver.' Gastroenterology 76(4): 710-9. Roman, McDonald et al (1992). 'Expression of fibronectin, the integrins α5 and α-smooth muscle actin in heart and lung development.' Am. J. Respir. Cell Mol. Biol. 6:472-80 Rose, C. (1990). 'Systemic therapy of metastatic breast cancer.' Acta Oncol 29(3): 361-5. Rutka, J. T., G. Apodaca, et al. (1988). 'The extracellular matrix of the central and peripheral nervous systems: structure and function.' J Neurosurg 69(2): 155-70. Saeki, T. and S. Takashima (2004). 'Capecitabine plus docetaxel combination chemotherapy for metastatic breast cancer.' Breast Cancer 11(2): 116-20. Schatton, T., G. F. Murphy, et al. (2008). 'Identification of cells initiating human melanomas.' Nature 451(7176): 345-9. Schibler, M. J. and F. Cabral (1986). 'Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha- and beta-tubulin.' J Cell Biol 102(4): 1522-31. Schmid, P. and K. Possinger (2006). '[Chemotherapy for metastatic breast cancer].' Zentralbl Gynakol 128(6): 318-26. Sheridan, C., H. Kishimoto, et al. (2006). 'CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis.' Breast Cancer Res 8(5): R59. Schuger and O'Shea et al. (1990). 'Organotypic arrangement of mouse embryonic lung cells on a basement membrane extract: involvement of laminin.' Development 110: 1091-9 Schuger and Skubitzz et al. (1991). 'Identification of laminin domains involved in branching morphogenesis: effects of anti-laminin monoclonal antibodies on mouse embryonic lung development.' Dev. Biol. 146: 531-41 Singh, S. K., I. D. Clarke, et al. (2003). 'Identification of a cancer stem cell in human brain tumors.' Cancer Res 63(18): 5821-8. Stallcup, W. B., R. Pytela, et al. (1989). 'A neuroectoderm-associated ganglioside participates in fibronectin receptor-mediated adhesion of germinal cells to fibronectin.' Dev Biol 132(1): 212-29. Subarsky, P. and R. P. Hill (2003). 'The hypoxic tumour microenvironment and metastatic progression.' Clin Exp Metastasis 20(3): 237-50. Sullivan, R. and C. H. Graham (2007). 'Hypoxia-driven selection of the metastatic phenotype.' Cancer Metastasis Rev 26(2): 319-31. Valentijn, A. J., N. Zouq, et al. (2004). 'Anoikis.' Biochem Soc Trans 32(Pt3): 421-5. Vassilomanolakis, M., G. Koumakis, et al. (2005). 'First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer.' Breast 14(2): 136-41. Visvader, J. E. and G. J. Lindeman (2008). 'Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.' Nat Rev Cancer 8(10): 755-68. Wang, S., E. A. Konorev, et al. (2004). 'Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.' J Biol Chem 279(24): 25535-43. Yang, Z. F., P. Ngai, et al. (2008). 'Identification of local and circulating cancer stem cells in human liver cancer.' Hepatology 47(3): 919-28. Young S et al. (1995). 'Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis.' Dev. Biol. 161:615-25, 1994. Zhang, Z., K. Vuori, et al. (1995). 'The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.' Proc Natl Acad Sci U S A 92(13): 6161-5. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/43876 | - |
dc.description.abstract | 根據衛生署統計資料,乳癌為國人女性第二好發癌症,而且是癌症死因的第四位,可見乳癌威脅女性健康愈趨嚴重。對大多數乳癌病人來說,乳癌轉移造成的威脅是最大的,多數乳癌病患是死於乳癌轉移,而化療常用於治療乳癌轉移的病患,而癌症細胞對抗癌藥產生抗藥性通常會造成化療上的失敗。在最近報告指出,癌幹細胞(cancer stem cell)與癌症轉移以及癌症細胞抗藥性產生有很大的關係。我們想了解癌幹細胞在癌症轉移中抗藥性產生的情形,推測癌幹細胞在轉移中,受到轉移部位環境的影響進而產生抗藥性。我們利用乳腺球細胞(mammosphere)的培養方法篩選出一群癌幹細胞,將這群癌幹細胞培養在不同細胞外基質(extracellular matrix),探討不同細胞外基質對癌幹細胞抗藥性產生的影響。在我們的結果發現,癌細胞在乳腺球細胞的形成過程中,會發生上皮-間質轉化(epithelial-mesenchymal transition),也看到integrin α6, β1, β4表現的改變。乳腺球細胞對不同的細胞外間質的貼附能力是不同的,乳腺球細胞傾向貼附於膠原蛋白(collagen)和纖維蛋白(fibronectin),而不貼附於層粘蛋白(laminin)。而當乳腺球細胞貼附在膠原蛋白,這群乳腺球細胞會對常用於乳癌治療上的抗癌藥,像是epirubicin, doxorubicin, paclitaxel, etoposide,有抗藥性的產生。而必須更進一步去了解細胞外間質對癌細胞抗藥性產生的詳細機轉,以解決臨床上化療失敗的問題及可能提供新的癌症治療方向。 | zh_TW |
dc.description.abstract | Breast cancer is the second most common type cancer in women in Taiwan, and the fourth most common cause of cancer death. Most breast cancer patients die from tumor metastasis rather than from their primary tumors. In clinical, chemotherapy is usually given to treat breast cancer metastasis. Chemotherapy often fails to cure metastatic breast cancer due to drug resistance. In previous studies, cancer stem cells were involved in tumor metastasis and drug resistance. We hypothesize that microenvironment of metastatic sites, such like extracellular matrix may induce drug resistance of breast cancer stem cells. We isolated breast cancer stem cells by forming of mammosphere, and found the existence of epithelial-mesenchymal transition during mammosphere formation. We also observed that the expression of integrin α6, β1, β4 change during mammosphere formation. Mammospheres show different adhesion ability with various extracellular matrixes. Breast cancer stem cells favor to adhere on collagen type I, III, IV and fibronectin. Furthermore, adhesion of mammospheres to different collagen types enhanced drug resistance of epirubicin, doxorubicin, paclitaxel, etoposide. To further investigate the detailed mechanism of extracellular matrix-induced drug resistance on breast cancer stem cells is essential to solve the problem of chemotherapy fail in clinical and provide a new therapy target in breast metastatic tumor treatment. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T02:31:20Z (GMT). No. of bitstreams: 1 ntu-98-R96443018-1.pdf: 1837794 bytes, checksum: 884d12587e123ee228b77a093f38d299 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | Contents
Abbreviation……………………………………………………………………………i Chinese Abstract……………………………………………………………………….ii English Abstract……………………………………………………………………….iii Chapter 1 Introduction………………………………………………………………1 1.1 Breast cancer…………………………………………………………………2 1.2 Cancer stem cell……………………………………………………………...4 1.2.1 Cancer stem cell overview……………………………………………..4 1.2.2 Cancer stem cells in tumor metastasis…………………………………5 1.2.3 Cancer stem cells in drug resistance and tumor recurrence……………8 1.2.4 Isolation of cancer stem cells…………………………………………..9 1.2.5 Mammosphere……………………………………..………………….10 1.3 Motivation…………………………………………………………………..12 1.4 Aim………………………………………………………………………….13 Chapter 2 Materials and Methods…………………………………………………..14 2.1 Cell line culture……………………………………………………………..15 2.2 Mammosphere culture from MCF7…………………………………………15 2.3 Mammosphere culture from clinical samples…………………………….....16 2.4 Mammosphere adherent assay………………………………………………17 2.5 Cell culture in extracellular matrix (ECM)………………………………….17 2.6 Drug sensitivity assay……………………………………………………….18 2.7 Reverse transcription-polymerase chain reaction (RT-PCR)………………..19 2.7.1 Total RNA extraction……………………………………………….....19 2.7.2 Reverse transcription (RT)…………………………………………….20 2.7.3 Polymerase chain reaction (PCR)……………………………………..20 2.8 Real time RT-PCR……………………………………………………………21 Chapter 3 Results…………..…………………………………………………...……22 3.1 A small population of MCF7 can survive in non-adherent condition and generate mammospheres…………………………………………………….23 3.2 EMT and the change of integrins during mammosphere formation…………23 3.3 The adhesion ability of mammosphere on various ECM………………..…...24 3.4 ECM-induced change of epirubicin sensitivity in MCF7 mammospheres…...25 3.5 ECM-induced change of docetaxel sensitivity in MCF7 mammospheres…...25 3.6 ECM-induced change of doxorubicin sensitivity in MCF7 mammospheres...26 3.7 ECM-induced change of paclitaxel sensitivity in MCF7 mammospheres…...27 3.8 ECM-induced change of etoposide sensitivity in MCF7 mammospheres…...27 3.9 Effect of ECM on cancer stem cell survival upon treatment with anticancer drugs……………………………………………………................................28 3.10 Mammosphere formation and metastasis ability under different oxygen condition..……………………………………………………………………28 Chapter 4 Discussion…………………………………………………………………30 4.1 The mechanism of cancer stem cells adhesion on ECM…………………......31 4.2 The possible mechanism of ECM-induced drug resistance…………………..33 4.3 An attractive link with clinical treatment…………………………………….35 Figures and tables………………………………………………………………….…...37 Reference………………………………………………………………………….……54 Appendix………………………………………………………………………….…....62 Table of Figures Figure 1. Mammosphere formation form MCF7……………………………….…38 Figure 2. Gene expression of MCF7 and MCF7 mammosphere………………….39 Figure 3. The adhesion of mammosphere to differentECM………………….......40 Figure 4. Effect of ECM on epirubicin sensitivity for MCF7 mammosphere…….41 Figure 5. Effect of ECM on docetaxel sensitivity for MCF7 mammosphere……..42 Figure 6. Effect of ECM on doxorubicin sensitivity for MCF7 mammosphere…..43 Figure 7. Effect of ECM on paclitaxel sensitivity for MCF7 mammosphere……..44 Figure 8. Effect of ECM on etoposide sensitivity for MCF7 mammosphere……...45 Figure 9. Effect of several ECM on cancer stem cell survival upon treatment with anticancer drugs………………………………….……………...……....46 Figure 10. Mammosphere formation ration in different oxygen conditions………..47 Figure 11. Mammosphere metastasis ability in different oxygen conditions……….49 Figure 12. The adhesion ability of mammosphere on various ECM in 1% oxygen condition………………………………………………………………....51 Table 1. The adhesion ability of mammosphere on various ECM in 1% oxygen condition………………………………………………………………....53 | |
dc.language.iso | en | |
dc.title | 乳癌癌細胞轉移與抗藥性產生之探討 | zh_TW |
dc.title | The Study for the Mechanism of Drug Resistance
in Breast Cancer Metastasis | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 黃彥華(Yen-Hua Huang),張金堅 | |
dc.subject.keyword | 癌幹細胞,上皮-間質轉化,細胞外間質,抗藥性, | zh_TW |
dc.subject.keyword | cancer stem cell,epithelial-mesenchymal transition,integrin,extracellular matrix,drug resistance, | en |
dc.relation.page | 63 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-08-17 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 1.79 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。